Target
Tyrosine-protein kinase BTK [14-552]
Ligand
BDBM324281
Substrate
n/a
Meas. Tech.
In Vitro BTK Kinase Assay
IC50
<1.000±n/a nM
Citation
 Hopkins, BTMa, BPrince, RMarx, ILyssikatos, JPZheng, FPeterson, MPatience, DB Inhibiting agents for bruton's tyrosine kinase US Patent  US11858926 Publication Date 1/2/2024 
Target
Name:
Tyrosine-protein kinase BTK [14-552]
Synonyms:
Tyrosine-protein kinase BTK (14-552)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
62318.43
Organism:
Homo sapiens (Human)
Description:
Q06187[14-552]
Residue:
539
Sequence:
SQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILENRNGSLKPGSSHRKTKKPLPPTPEEDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDSSKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELINYHQHNSAGLISRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT
  
Inhibitor
Name:
BDBM324281
Synonyms:
(R)-1-(tert-butyl)-N-(8-(2-((1-isopropyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide | US10189829, Compound 25 | US10227341, Compound 25 | US10961237, Compound 25 | US11858926, Compound 25
Type:
Small organic molecule
Emp. Form.:
C30H38N10O2
Mol. Mass.:
570.6885
SMILES:
CC(C)n1cc(Nc2nccc(n2)-c2ccc3[C@@H](CCN(Cc3c2)C2COC2)NC(=O)c2cn(nn2)C(C)(C)C)cn1 |r|
Structure:
Search PDB for entries with ligand similarity: